Upgrade to SI Premium - Free Trial

Curis (CRIS)

1.35 -0.02 (1.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 10-Q CURIS INC For: Jun 30 August 14, 2026 4:05 PM - SEC Filing Form 424B4 CURIS INC August 13, 2026 5:27 PM - SEC Filing Curis prices $5.6M public offering at $1.50 per share August 13, 2026 8:01 AM - StreetInsider Curis, Inc. Announces Pricing of $5.6 Million Public Offering August 13, 2026 8:00 AM - PR NewsWire Form EFFECT CURIS INC August 13, 2026 6:06 AM - SEC Filing Form S-1 CURIS INC August 10, 2026 5:30 PM - SEC Filing Form 8-K CURIS INC For: Jul 24 July 30, 2026 4:02 PM - SEC Filing Curis doses first five patients in CLL study, eyes December data July 30, 2026 8:02 AM - StreetInsider Curis Doses First Five Patients in TakeAim CLL Study July 30, 2026 8:00 AM - PR NewsWire Curis (CRIS) PT Raised to $43 at H.C. Wainwright July 24, 2026 7:31 AM - StreetInsider Curis reports updated emavusertib trial data in PCNSL and CLL July 22, 2026 7:01 AM - StreetInsider Curis Announces Positive Emavusertib Update July 22, 2026 7:00 AM - PR NewsWire Form 4 CURIS INC For: Jul 07 Filed by: Rubin Marc July 9, 2026 4:13 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: KAITIN KENNETH I July 9, 2026 4:12 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: Hohneker John July 9, 2026 4:12 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: GREENACRE MARTYN D July 9, 2026 4:12 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: Borgman Anne Elizabeth July 9, 2026 4:12 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: Duvall Diantha July 9, 2026 4:11 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: Zung Jonathan B. July 9, 2026 4:10 PM - SEC Filing Form 4 CURIS INC For: Jul 07 Filed by: Dentzer James E July 9, 2026 4:09 PM - SEC Filing Curis Consents First Six Patients in TakeAim CLL Study July 6, 2026 9:30 AM - PR NewsWire Form 8-K CURIS INC For: Jul 02 July 2, 2026 8:56 AM - SEC Filing Form 8-K/A CURIS INC For: Jul 01 July 1, 2026 11:23 AM - SEC Filing Form 8-K CURIS INC For: Jun 25 July 1, 2026 8:02 AM - SEC Filing Curis opens 11 CLL trial sites, stockholders approve reverse split June 26, 2026 9:43 AM - StreetInsider Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split June 26, 2026 9:43 AM - PR NewsWire Form 8-K CURIS INC For: Jun 25 June 25, 2026 4:02 PM - SEC Filing Full Article List